Case report: Branch retinal vein occlusion and primary antiphospholipid syndrome

被引:5
作者
Ali, Oliver [1 ]
Slagle, William Scott [1 ,2 ,4 ]
Hamp, Ania M. [3 ]
机构
[1] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA
[2] Virginia Tech Carilion Sch Med, Roanoke, VA USA
[3] WG Hefner Vet Affairs Med Ctr, Salisbury, NC USA
[4] Edward Via Virginia Coll Osteopath, Blacksburg, VA USA
关键词
Antiphospholipid syndrome; Retinal vein occlusion; Venous thrombosis; Hypercoagulability; Anticardiolipin antibodies; beta-2-glycoportein; 1; Lupus coagulation inhibitor; PREVALENCE; THROMBOSIS;
D O I
10.1016/j.optm.2010.07.032
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BACKGROUND: Branch retinal vein occlusion (BRVO) is commonly encountered in older patients with vascular disease. This report presents a case of BRVO in an atypically young patient that precipitated additional testing and a subsequent diagnosis of primary antiphospholipid syndrome. This illustrates a need for a thrombophilic evaluation in atypical patients. CASE REPORT: A 33-year-old white man presented with a BRVO in the left eye. Laboratory studies found the presence of persistently elevated anticardiolipin immunoglobulin G and immunoglobulin M antibodies in the absence of causative systemic disease, conferring the diagnosis of primary antiphospholipid syndrome and supporting a thrombotic component of this BRVO. CONCLUSION: The presentation of a BRVO in young patients with minimal observable retinal effects from classic BRVO risk factors may indicate the necessity of a hematologic evaluation to determine possible compounding causes. Here we show a methodical inspection of the cause of an atypical BRVO and, more specifically, consideration for hypercoagulable pathologies and their treatment in such patient encounters. Optometry 2011;82:428-433
引用
收藏
页码:428 / 433
页数:6
相关论文
共 22 条
[21]   Homocysteine and MTHFR mutations - Relation to thrombosis and coronary artery disease [J].
Varga, EA ;
Sturm, AC ;
Misita, CP ;
Moll, S .
CIRCULATION, 2005, 111 (19) :E289-E293
[22]  
YANNUZZI LA, 1993, AM J OPHTHALMOL, V116, P286